Aethlon Medical, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
AEMD Nasdaq 3840 www.aethlonmedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aethlon Medical, Inc.

Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger - Sep 17th, 2026 6:36 am
North Immunology joins biotech reverse merger boom with Aethlon deal - Sep 17th, 2026 5:09 am
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis - Sep 17th, 2026 4:30 am
AEMD: Oncology Study Advances; Cost-Efficient Preclinical Activities Regarding Other Diseases Continue - Aug 19th, 2026 4:36 am
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream - Aug 18th, 2026 5:00 am
Aethlon Medical, Inc. Q1 2027 Earnings Call Summary - Aug 14th, 2026 6:30 am
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program - Aug 13th, 2026 2:15 pm
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 - Aug 5th, 2026 6:01 am
Presenting on Emerging Growth Conference 94 Day 2 on July 16; Register to live stream - Jul 15th, 2026 5:00 am
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier® - Jul 13th, 2026 6:01 am
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - Jul 6th, 2026 7:25 am
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier® - Jun 26th, 2026 6:01 am
Aethlon Medical advances Hemopurifier study as final trial cohort nears completion - Jun 17th, 2026 10:18 am
Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Strategic Advances Amid Financial ... - Jun 16th, 2026 7:00 pm
AEMD: Clinical Study Advances to Final Cohort; Preclinical Activities Expand - Jun 11th, 2026 9:18 am
Aethlon Medical, Inc. Q4 2026 Earnings Call Summary - Jun 11th, 2026 6:30 am
Aethlon (AEMD) Q4 2026 Earnings Transcript - Jun 10th, 2026 4:15 pm
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update - Jun 10th, 2026 2:15 pm
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 - Jun 2nd, 2026 6:01 am